Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
coronary artery disease
MedTech
J&J trials IVL-first strategy in women with blocked coronaries
The trial tested Shockwave Medical's vessel-clearing approach as the primary procedure for women with calcified blockages in the coronary arteries.
Conor Hale
May 20, 2025 11:45am
J&J's Shockwave to test Javelin lithotripsy in coronary arteries
Apr 7, 2025 10:50am
Supira Medical collects $120M for its catheter-based heart pump
Mar 26, 2025 11:26am
Abbott launches coronary intravascular lithotripsy trial
Mar 24, 2025 11:35am
Boston Scientific zaps Bolt in intravascular lithotripsy buy
Jan 8, 2025 11:00am
Cleerly collects $106M for its coronary artery scanning AI
Dec 5, 2024 2:50pm
